Himalaya Nutradetics: Kerala Supplies 90% of Contract Revenue

Himalaya Nutradetics has substantial Kerala exposure because the state supplies approximately 90% of third-party contract-manufacturing revenue. Kerala also generated Rs 21.2472 crore, or 49.33%, of total revenue in the year ended March 31, 2026, although its company-wide share declined from 68.92% a year earlier.

How dependent is Himalaya Nutradetics on Kerala?

Himalaya Nutradetics is highly dependent on Kerala for third-party contract manufacturing because the state contributes approximately 90% of that segment’s revenue. Third-party manufacturing produced Rs 21.0421 crore, or 48.86% of total revenue, for the year ended March 31, 2026. Himalaya Nutradetics attributes the Kerala concentration to long-standing customer relationships and established manufacturing capabilities.

Kerala is less concentrated within total revenue than within the contract-manufacturing segment because Himalaya Nutradetics also sells its own brands. Kerala contributed Rs 21.2472 crore of the company’s Rs 43.0675 crore total revenue in fiscal 2026. The difference between Kerala’s 49.33% total-revenue share and its approximately 90% contract-manufacturing share indicates that the principal geographic dependency lies with third-party clients.

Himalaya Nutradetics operates a single integrated manufacturing facility in Hyderabad, Telangana, for Ayurvedic and nutraceutical products. The facility handles formulation, production, in-process quality checks, packaging and finished-goods release, while third-party customers determine branding, marketing, distribution and commercial strategy. Kerala contract revenue therefore depends on purchase orders from those customers, plant capacity and compliance with agreed specifications and manufacturing requirements.

Why did Kerala's share of total revenue fall in fiscal 2026?

Kerala’s share of total revenue fell in fiscal 2026 because company-wide sales grew faster than Kerala revenue. Kerala revenue increased to Rs 21.2472 crore in fiscal 2026 from Rs 14.4712 crore in fiscal 2025, but its share declined to 49.33% from 68.92%. Total revenue rose to Rs 43.0675 crore from Rs 20.9965 crore over the same period.

Gujarat and Uttar Pradesh accounted for much of the changed geographic mix in fiscal 2026. Gujarat generated Rs 5.6875 crore, or 13.21% of total revenue, compared with a 0.02% share in fiscal 2025. Uttar Pradesh generated Rs 5.0318 crore, or 11.68%, compared with 3.17% in fiscal 2025.

The two states together represented 24.89% of fiscal 2026 revenue, compared with 3.19% in fiscal 2025. Telangana, which had accounted for 28.68% of revenue in fiscal 2024, contributed 9.49% in fiscal 2026, or Rs 4.0882 crore. The geographic data show a broader distribution of total sales, but they do not separately identify own-brand and contract-manufacturing revenue by state.

How did the business mix change alongside Kerala concentration?

Himalaya Nutradetics shifted toward own-brand revenue in fiscal 2026, reducing the share of total sales supplied by third-party manufacturing. Own-brand revenue was Rs 22.0254 crore, or 51.14% of total revenue, in the year ended March 31, 2026. Third-party manufacturing was Rs 21.0421 crore, or 48.86%.

The position was materially different in fiscal 2025, when third-party manufacturing represented 80.35% of revenue and own-brand business represented 19.65%. Contract-manufacturing revenue increased from Rs 16.8716 crore in fiscal 2025 to Rs 21.0421 crore in fiscal 2026, but own-brand revenue increased from Rs 2.1249 crore to Rs 22.0254 crore. That faster growth changed the revenue mix without eliminating Kerala’s stated importance to the contract segment.

Himalaya Nutradetics defines its own-brand portfolio as classical Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements. Classical Ayurvedic formulations follow recognised Ayurvedic texts under the Ministry of Ayush framework, while nutraceutical supplements are regulated under the Food Safety and Standards Act, 2006 and applicable Food Safety and Standards Authority of India regulations. The portfolio is manufactured at the Hyderabad facility across dosage forms including softgel capsules, tablets, liquid orals and medicated oils.

What supports sales outside Kerala?

Himalaya Nutradetics supports branded-product sales through a stockist-driven and doctor-engagement-led offline model. As of July 31, 2026, approximately 58 sales and marketing personnel supported distribution across various Indian states. The field force conducts scientific detailing, continuing medical education programmes and medical camps to build practitioner awareness and prescription-led demand.

Under the distribution model, Himalaya Nutradetics makes primary sales to stockists and super-stockists, which then supply pharmacies and clinics in response to secondary demand. Stockists may be appointed at district or local level, while super-stockists may operate at regional or state level. Commercial arrangements may include credit periods, trade discounts and margins that vary by geography, order profile and market conditions.

The Gujarat and Uttar Pradesh revenue reported for fiscal 2026 must therefore be supported by both channel availability and practitioner engagement if it is to persist. Himalaya Nutradetics receives periodic information from stockists on inventory levels, primary purchases and onward sales for operational planning. The disclosure does not provide state-level stockist counts, state-level own-brand revenue or a sales target for either Gujarat or Uttar Pradesh.

How concentrated are customers and what is management's plan?

Himalaya Nutradetics also reports customer concentration alongside its Kerala exposure. Its largest customer generated Rs 15.515 crore, or 36.02% of revenue from operations, in fiscal 2026. The top three customers accounted for Rs 24.2584 crore, or 56.53%, while the top 10 customers accounted for Rs 34.9875 crore, or 81.24%.

The largest customer’s share declined from 49.54% in fiscal 2025, while the top-10 customer share declined from 86.97%. However, the largest customer’s revenue increased from Rs 10.4018 crore in fiscal 2025 to Rs 15.515 crore in fiscal 2026. The disclosed data show that revenue expanded outside the largest customer group, but more than four-fifths of fiscal 2026 operating revenue still came from the top 10 customers.

Himalaya Nutradetics says management continuously evaluates opportunities to broaden the geographic spread of third-party manufacturing clients to mitigate regional concentration risk and support scalable growth. This is an evaluation rather than a disclosed target, contract or timetable. The company also states that it selectively undertakes third-party assignments according to operational capacity and strategic objectives.

Conclusion

Himalaya Nutradetics’ fiscal 2026 disclosures show that Kerala remains central to third-party manufacturing while total revenue has become less concentrated in the state. Kerala supplied approximately 90% of contract-manufacturing revenue and Rs 21.2472 crore of total sales, but its total-revenue share fell by 19.59 percentage points from fiscal 2025 as Gujarat and Uttar Pradesh became larger contributors.

The next point to watch is whether Himalaya Nutradetics converts its stated review of third-party client diversification into revenue outside Kerala. The unresolved issue is whether the approximately 10% of contract-manufacturing revenue from other states can increase while Kerala customers continue placing orders and the fiscal 2026 sales contribution from Gujarat and Uttar Pradesh is maintained.